Biblio
Targeted checkpoint control of B cells undergoing positive selection in germinal centers by follicular regulatory T cells. Proc Natl Acad Sci U S A. 2024;121(5):e2304020121.
. Targeted CRISPR activation is functional in engineered human pluripotent stem cells but undergoes silencing after differentiation into cardiomyocytes and endothelium. Cell Mol Life Sci. 2024;81(1):95.
. Targeted Delivery of Mesenchymal Stem Cell-Derived Bioinspired Exosome-Mimetic Nanovesicles with Platelet Membrane Fusion for Atherosclerotic Treatment. Int J Nanomedicine. 2024;19:2553-2571.
. Targeted Gene Insertion: The Cutting Edge of CRISPR Drug Development with Hemophilia as a Highlight. BioDrugs. 2024.
. Targeted Metabolomics on Rare Primary Cells. J Vis Exp. 2024;(204).
Targeted Sequencing of Circular RNAs for Illumina-Based Counting and Nanopore Structure Determination. Methods Mol Biol. 2024;2765:127-142.
. Targeted therapies in retinoblastoma: GD2-directed immunotherapy following autologous stem cell transplantation and evaluation of alternative target B7-H3. Cancer Immunol Immunother. 2024;73(1):19.
Targeting ABCA1 via Extracellular vesicle-Encapsulated Staurosporine as a Therapeutic Strategy to enhance Radiosensitivity. Adv Healthc Mater. 2024:e2400381.
. Targeting adenosine A receptors for early intervention of retinopathy of prematurity. Purinergic Signal. 2024.
. Targeting bone homeostasis regulation: potential of traditional Chinese medicine flavonoids in the treatment of osteoporosis. Front Pharmacol. 2024;15:1361864.
. Targeting brain tumors with innovative nanocarriers: bridging the gap through the blood-brain barrier. Oncol Res. 2024;32(5):877-897.
. Targeting cancer stem cell OXPHOS with tailored ruthenium complexes as a new anti-cancer strategy. J Exp Clin Cancer Res. 2024;43(1):33.
Targeting cancer-associated fibroblast autophagy renders pancreatic cancer eradicable with immunochemotherapy by inhibiting adaptive immune resistance. Autophagy. 2024.
Targeting CD20-expressing malignant melanoma cells augments BRAF inhibitor killing. Br J Dermatol. 2024.
. Targeting CD73 with flavonoids inhibits cancer stem cells and increases lymphocyte infiltration in a triple-negative breast cancer mouse model. Front Immunol. 2024;15:1366197.
Targeting Cervical Cancer Stem Cells by Phytochemicals. Curr Med Chem. 2024.
. Targeting DEP domain containing 1 in anaplastic thyroid carcinoma: Implications for stemness regulation and malignant phenotype suppression. Heliyon. 2024;10(5):e27150.
. Targeting EMSY-mediated methionine metabolism is a potential therapeutic strategy for triple-negative breast cancer. Cell Rep Med. 2024:101396.
. Targeting ferroptosis for leukemia therapy: exploring novel strategies from its mechanisms and role in leukemia based on nanotechnology. Eur J Med Res. 2024;29(1):224.
. Targeting mitochondrial bioenergetics by combination treatment with imatinib and dichloroacetate in human erythroleukemic K‑562 and colorectal HCT‑116 cancer cells. Int J Oncol. 2024;64(4).
. Targeting MYC at the intersection between cancer metabolism and oncoimmunology. Front Immunol. 2024;15:1324045.
. Targeting myostatin using quercetin as a media supplement to improve myogenesis for cultured meat production: An and study. Curr Res Food Sci. 2024;8:100678.
. Targeting nuclear receptor corepressors for reversible male contraception. Proc Natl Acad Sci U S A. 2024;121(9):e2320129121.